Galderma Buy Will Boost L'Oreal EPS by 2% -- Market Talk
Dow Jones12-08
1334 GMT - L'Oreal's move to double its stake in Galderma will increase the cosmetics company's earnings-per-share by 2%, analysts at J.P. Morgan write. The deal will also bring L'Oreal's debt-to-earnings ratio into the green. The deal leaves the door open for L'Oreal to further increase its stake in the Swiss dermatology group, the analysts say. However, the Paris-listed company said no such increases are planned. L'Oreal shares fall 2.4% to 363.90 euros. Galderma shares rise 2% to 166.10 Swiss francs. (josephmichael.stonor@wsj.com)
(END) Dow Jones Newswires
December 08, 2025 08:34 ET (13:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments